Michele Gunning
Psychiatry · Peterborough, NHNPI 1144421132
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 337 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 56.0% of the total. Among psychiatry clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 337 payments — averaging $23.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Neurocrine Biosciences, Inc.$497
- Vanda Pharmaceuticals Inc.$461
- Johnson & Johnson$447
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$360
- Lundbeck LLC$347
- plus $1K from 17 others
What the payments were for
- Food & beverage$7,71498%
- Education$1672%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 199 | $4,414 |
| Neurocrine Biosciences, Inc. | 13 | $497 |
| Vanda Pharmaceuticals Inc. | 14 | $461 |
| Johnson & Johnson | 2 | $447 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 22 | $360 |
| Lundbeck LLC | 27 | $347 |
| Alkermes, Inc. | 7 | $237 |
| Ironshore Pharmaceuticals Inc. | 7 | $152 |
| Axsome Therapeutics, Inc. | 7 | $145 |
| Collegium Pharmaceutical, Inc. | 7 | $119 |
| Teva Pharmaceuticals USA, Inc. | 2 | $114 |
| E.r. Squibb & Sons, L.L.C. | 5 | $103 |
| Corium, LLC | 4 | $78 |
| Indivior Inc. | 4 | $70 |
| Supernus Pharmaceuticals, Inc. | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Orexo US, Inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Sunovion Pharmaceuticals Inc. | 1 | $27 |
| Neos Therapeutics, LP | 1 | $23 |
| Biogen | 1 | $22 |
| Bioxcel Therapeutics, Inc. | 1 | $19 |
| Harmony Biosciences LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,882 in reported general payments places this provider in the 90th percentile of 166 psychiatry providers in New Hampshire.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 98 | $168,522 |
| CaplytaLumateperone Tosylate | 25 | $44,413 |
| BelsomraSuvorexant | 53 | $25,811 |
| EmsamSelegiline | 12 | $25,125 |
| Lisdexamfetamine Dimesylate | 88 | $24,641 |
| Lurasidone Hcl | 32 | $20,213 |
| TrintellixVortioxetine Hydrobromide | 25 | $18,033 |
| Duloxetine Hcl | 140 | $18,028 |
| Aripiprazole | 87 | $15,480 |
| Lamotrigine ErLamotrigine | 55 | $13,332 |
| Topiramate ErTopiramate | 17 | $12,972 |
| AdderallDextroamphetamine/Amphetamine | 13 | $11,616 |
| Adderall XrDextroamphetamine/Amphetamine | 31 | $9,728 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 73 | $9,470 |
| Quetiapine Fumarate | 298 | $8,163 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $4,414 | $168,52298 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $360 | $44,41325 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Adderall, Vyvanse | $39 | $34,83852 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 166 psychiatry providers in New Hampshire.
Other psychiatry in Peterborough
- Teresa CadorettePeterborough$4K
- John MillerExeter$2.7M
- Stephen EllenNashua$1.4M
- Michael McNamaraManchester$754K
- Kenneth BrownBrentwood$94K
- Janet CarellaManchester$82K
- Robert CotesLebanon$64K
- Quentin TurnbullManchester$25K
- Paul LidstromLittleton$14K
- Juliette MadanLebanon$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.